Lead: A µ-opioid receptor superagonist analgesic with minimal adverse effects

Lead: A µ-opioid receptor superagonist analgesic with minimal adverse effects

A µ-opioid receptor superagonist analgesic with minimal adverse effects

Nature

This study identifies a novel µ-opioid receptor (MOR) agonist with supramaximal intrinsic efficacy and a unique pharmacological profile that produced effective analgesia in rodents with minimal adverse effects. N-desethyl-fluornitrazene (DFNZ) was derived from a class of synthetic benzimidazole opioids called nitazenes. DFNZ has impaired brain penetrance, a unique spatiotemporal MOR cellular signaling profile, and diminished efficacy at the MOR–galanin 1 receptor (GAL1) heteromer. DFNZ does not induce respiratory depression, tolerance, or MOR downregulation after repeated exposure. Compared with other MOR agonists, DFNZ has limited effects on dopamine neurotransmission in the nucleus accumbens and weaker reinforcing effects in the drug self-administration procedure. These results provide novel insights about MOR and nitazene pharmacology, have important implications for pain and addiction treatment, and challenge the prevailing dogma that high-efficacy MOR agonists cannot constitute safe and effective therapeutic agents.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(100)

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction Cocaine use disorder (CUD) is an increasingly wi...

11 Elo 7min

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

2025 National Survey on Drug Use and Health (NSDUH) SAMHSA The 2025 National Survey on Drug Use and Health (NSDUH) shows encouraging trends among adolescents and young adults with broad declines acros...

4 Elo 7min

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study BMJ Open This retrospective cohort study usi...

28 Heinä 6min

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Trends in alcohol-related deaths in the United States over 55 years: 1968-2023 Alcohol, Clinical and Experimental Research  This study of alcohol-related mortality trends since 1968 used primarily dea...

21 Heinä 6min

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians  Journal of Substance Use and Addiction Treatment  Few patients with opioid use disorder (OUD) receive medications for ...

14 Heinä 7min

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial JAMA Network Open This randomized clinical trial of 340 adults with opio...

7 Heinä 7min

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week Journal of Studies on Alcohol and Drugs This study used a cause-specific...

30 Kesä 6min

Lead: Social media use trajectories and substance use experimentation: A prospective cohort study

Lead: Social media use trajectories and substance use experimentation: A prospective cohort study

Social media use trajectories and substance use experimentation: A prospective cohort study The American Journal of Psychiatry An analysis of data from more than 7,000 adolescents over 5 years found s...

23 Kesä 8min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
politiikan-puskaradio
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
otetaan-yhdet
rss-vaalirankkurit-podcast
rss-podme-livebox
rss-seksicast
tervo-halme
rikosmyytit
aihe
rss-raha-talous-ja-politiikka
the-ulkopolitist
rss-bimbolia
rss-vain-talouselamaa
rss-merja-mahkan-rahat
rss-kaikki-uusiksi
rss-50100-podcast
et-sa-noin-voi-sanoo-esittaa